There’s a ton of research and development in the pharmaceutical sector – but in the education system, which is just as large, there’s virtually none. 17 percent of pharma’s revenues are reinvested in R&D – but with education, the figure is just 0.1 percent. Aneesh Chopra, Chief Technology Officer of the United States, calls this a missed opportunity – and notes that Washington is trying to spur startups to focus on this – in this Entrepreneur Thought Leader Lecture given at Stanford University.
VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn More